# Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas

> **NCT03687294** · — · UNKNOWN · sponsor: **Cairo University** · enrollment: 70 (estimated)

## Conditions studied

- Malignant Neoplasm of Salivary Gland
- Benign Neoplasm of Salivary Gland

## Interventions

- **DEVICE:** enzyme linked immunosorbent assay (ELISA)

## Key facts

- **NCT ID:** NCT03687294
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-12
- **Primary completion:** 2021-09
- **Final completion:** 2021-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2020-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03687294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03687294, "Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03687294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*